Compile Data Set for Download or QSAR
Report error Found 1031 for UniProtKB: P62942
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513990(US11059830, Compound 1)
Affinity DataKd:  355nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513992(US11059830, Compound 2)
Affinity DataKd:  1.5nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513993(US11059830, Compound 3)
Affinity DataKd:  0.340nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513994(US11059830, Compound 4)
Affinity DataKd:  4.80nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513995(US11059830, Compound 5)
Affinity DataKd:  18.8nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513996((2S)-1-((4R,7S)-7-((2R,3S,4R,11 S,12R)-12-benzyl-3...)
Affinity DataKd:  0.510nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513997(US11059830, Compound 7)
Affinity DataKd:  0.950nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513998(US11059830, Compound 8)
Affinity DataKd:  1.10nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513999(US11059830, Compound 9)
Affinity DataKd:  785nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM514000((S)-1-(2-((2R,3R,6S)-6-((2R,3R,4S,6E,9E,11R,12R)-1...)
Affinity DataKd:  0.210nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513990(US11059830, Compound 1)
Affinity DataKd:  71.5nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513992(US11059830, Compound 2)
Affinity DataKd:  12.6nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513993(US11059830, Compound 3)
Affinity DataKd:  1.30nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513994(US11059830, Compound 4)
Affinity DataKd:  23.1nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513995(US11059830, Compound 5)
Affinity DataKd:  7nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM513996((2S)-1-((4R,7S)-7-((2R,3S,4R,11 S,12R)-12-benzyl-3...)
Affinity DataKd:  21.5nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597680(US11603377, Compound 1)
Affinity DataKd: >1nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597681(US11603377, Compound 2)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597682(US11603377, Compound 3)
Affinity DataKd:  0.650nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597683(US11603377, Compound 4)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597684(US11603377, Compound 5)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597685(US11603377, Compound 6)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597686(US11603377, Compound 7)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597687(US11603377, Compound 8)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597688(US11603377, Compound 9)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597689(US11603377, Compound 10)
Affinity DataKd:  0.650nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597690(US11603377, Compound 11)
Affinity DataKd:  0.650nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597691(US11603377, Compound 12)
Affinity DataKd:  0.650nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597692(US11603377, Compound 16 | US11603377, Compound 13)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597693(US11603377, Compound 14)
Affinity DataKd:  0.650nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597694(US11603377, Compound 15)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597692(US11603377, Compound 16 | US11603377, Compound 13)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597696(US11603377, Compound 17)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597697(US11603377, Compound 18)
Affinity DataKd:  0.650nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597698(US11603377, Compound 19)
Affinity DataKd:  0.650nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597699(US11603377, Compound 20)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597700(US11603377, Compound 21)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597701(US11603377, Compound 22)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597702(US11603377, Compound 23)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597703(US11603377, Compound 24)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597704(US11603377, Compound 25)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597705(US11603377, Compound 26)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597706(US11603377, Compound 27)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597707(US11603377, Compound 34 | US11603377, Compound 28)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597708(US11603377, Compound 35 | US11603377, Compound 29)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597709(US11603377, Compound 30)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597710(US11603377, Compound 31)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597711(US11603377, Compound 32)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597712(US11603377, Compound 33)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Human)
Revolution Medicines

US Patent
LigandPNGBDBM597707(US11603377, Compound 34 | US11603377, Compound 28)
Affinity DataKd: <0.300nMAssay Description:Biotinylated avi-FKBP12 was immobilized on a streptavidin chip (Cytiva Series S SA) using a Biacore 8K or 8 k+ (Cytiva). To achieve an immobilization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 1031 total ) | Next | Last >>
Jump to: